Literature DB >> 1352903

L-deprenyl in treating negative symptoms of schizophrenia.

A Perenyi, U Goswami, E Frecska, M Arató, A Bela.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1352903     DOI： 10.1016/0165-1781(92)90082-e

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


× No keyword cloud information.
  3 in total

1.  Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.

Authors:  Robert W Buchanan; Elaine Weiner; Deanna L Kelly; James M Gold; William R Keller; James A Waltz; Robert P McMahon; David A Gorelick
Journal:  Schizophr Bull       Date:  2014-11-02       Impact factor: 9.306

Review 2.  Potential drug targets and treatment of schizophrenia.

Authors:  Anil Kumar; Monu Yadav; Milind Parle; Sameer Dhingra; Dinesh K Dhull
Journal:  Inflammopharmacology       Date:  2017-03-28       Impact factor: 4.473

3.  Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.

Authors:  Ivan D Montoya; Frank Vocci
Journal:  J Dual Diagn       Date:  2007-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.